Core Viewpoint - Danone S.A. is under investigation for potential securities fraud and unlawful business practices following a contamination scare involving its infant milk formula products [1]. Group 1: Contamination Incident - On January 21, 2026, Danone recalled and blocked batches of its infant milk formula due to the detection of cereulide, a potent cytotoxin, in its Thai-origin Dumex Dulac 1 [2]. - Following this news, Danone's American Depositary Receipt (ADR) price dropped by $1.37, or 7.95%, closing at $15.87 per ADR on the same day [2]. - On January 23, 2026, Danone issued a press release announcing a recall of select batches of its infant formula to comply with updated guidance, resulting in an additional ADR price decline of $0.43, or 2.7%, to close at $15.55 per ADR [3]. Group 2: Legal Investigation - Pomerantz LLP is investigating claims on behalf of Danone investors regarding possible securities fraud or other unlawful business practices by the company and its officers and/or directors [1].